Life ScienceCompany
Heptares Therapeutics M&A Summary
Heptares Therapeutics has acquired 1 company of its own.
Heptares Therapeutics’ largest acquisition to date was in 2016, when it acquired G7 Therapeutics AG for $12M. The Company’s most targeted sectors include life science (100%).
Heptares Therapeutics Ownership
Who owns Heptares Therapeutics?
Heptares Therapeutics is owned by Nxera Pharma. It was acquired on February 22, 2015.
Heptares Therapeutics Business Overview
Where is Heptares Therapeutics headquartered?
Heptares Therapeutics is headquartered in Welwyn Garden City, United Kingdom.
What sector is Heptares Therapeutics in?
Heptares Therapeutics is a life science company.
When was Heptares Therapeutics founded?
Heptares Therapeutics was founded in 2007.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1